Insmed Correlations
INSM Stock | USD 78.94 1.95 2.53% |
The current 90-days correlation between Insmed Inc and Ascendis Pharma AS is 0.33 (i.e., Weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Insmed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Insmed Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Insmed Correlation With Market
Weak diversification
The correlation between Insmed Inc and DJI is 0.32 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Insmed Inc and DJI in the same portfolio, assuming nothing else is changed.
Insmed |
Moving together with Insmed Stock
0.8 | DMAC | DiaMedica Therapeutics | PairCorr |
0.71 | VALN | Valneva SE ADR | PairCorr |
0.76 | VERV | Verve Therapeutics | PairCorr |
0.85 | VIGL | Vigil Neuroscience | PairCorr |
0.74 | VRNA | Verona Pharma PLC | PairCorr |
0.67 | VRTX | Vertex Pharmaceuticals | PairCorr |
0.69 | VTVT | vTv Therapeutics | PairCorr |
Moving against Insmed Stock
0.78 | VINC | Vincerx Pharma Earnings Call Next Week | PairCorr |
0.63 | VKTX | Viking Therapeutics | PairCorr |
0.57 | VERA | Vera Therapeutics | PairCorr |
0.54 | DSGN | Design Therapeutics | PairCorr |
0.49 | ME | 23Andme Holding | PairCorr |
0.49 | DRRX | Durect Earnings Call This Week | PairCorr |
0.41 | DRMA | Dermata Therapeutics | PairCorr |
0.39 | CDIOW | Cardio Diagnostics | PairCorr |
0.36 | VANI | Vivani Medical Earnings Call This Week | PairCorr |
0.32 | SABSW | SAB Biotherapeutics | PairCorr |
0.64 | DYAI | Dyadic International Earnings Call This Week | PairCorr |
0.58 | VTYX | Ventyx Biosciences | PairCorr |
0.55 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.55 | VYNE | Vyne Therapeutics | PairCorr |
0.52 | VTRS | Viatris | PairCorr |
0.51 | VYGR | Voyager Therapeutics | PairCorr |
0.48 | VRAX | Virax Biolabs Group | PairCorr |
0.42 | VRDN | Viridian Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Insmed Stock performing well and Insmed Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Insmed's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ASND | 2.55 | 0.51 | 0.20 | 0.38 | 2.24 | 5.86 | 18.15 | |||
APLS | 2.17 | (0.39) | 0.00 | (0.48) | 0.00 | 4.11 | 20.77 | |||
BGNE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
AKRO | 4.34 | 1.19 | 0.33 | 0.60 | 2.98 | 4.92 | 104.81 | |||
BPMC | 2.13 | 0.06 | 0.00 | (0.04) | 0.00 | 5.39 | 26.30 | |||
CERE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
RNA | 2.84 | (0.07) | 0.00 | (0.15) | 0.00 | 6.64 | 13.42 | |||
RVMD | 1.74 | (0.19) | 0.00 | (0.27) | 0.00 | 4.37 | 11.35 | |||
DAWN | 2.84 | (0.57) | 0.00 | (0.74) | 0.00 | 6.36 | 22.86 | |||
SWTX | 3.78 | 0.47 | 0.12 | 0.61 | 3.91 | 7.53 | 41.82 |
Insmed Corporate Management
Mandy Fahey | Executive Communications | Profile | |
Sara MBA | Chief Officer | Profile | |
Nicole MBA | Chief Officer | Profile | |
John Wise | Head VP | Profile | |
Eleanor Barisser | Associate Relations | Profile | |
MD MBA | Chief Officer | Profile |